| scholarly article | Q13442814 |
| P2093 | author name string | Hong-Yan Wang | |
| Rui Xu | |||
| Zhao Jing | |||
| Hui Guo | |||
| Ke-Jun Nan | |||
| Zhi-Ping Ruan | |||
| Hai-Xia Qin | |||
| P2860 | cites work | Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit | Q24313542 |
| Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase | Q24320228 | ||
| The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers | Q24321912 | ||
| Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding | Q24550737 | ||
| History of the events leading to the formulation of the apoptosis concept | Q28634583 | ||
| Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. | Q33587671 | ||
| Replacement of Fhit in cancer cells suppresses tumorigenicity | Q33726007 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control | Q35552007 | ||
| Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma | Q36645962 | ||
| Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer | Q37355107 | ||
| Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters | Q38452555 | ||
| Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. | Q43640355 | ||
| Down-regulation of fragile histidine triad expression in prostate carcinoma | Q44356037 | ||
| Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer | Q44386099 | ||
| Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. | Q44452650 | ||
| Effect of FHIT gene replacement on growth, cell cycle and apoptosis in pancreatic cancer cells | Q44532679 | ||
| Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. | Q50889853 | ||
| Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. | Q53676079 | ||
| Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. | Q54311602 | ||
| Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression | Q64381393 | ||
| Alterations of the FHIT gene in human hepatocellular carcinoma. | Q64923037 | ||
| Regulation of proliferating cell nuclear antigen during the cell cycle | Q69372601 | ||
| Apoptosis and proliferation of human hepatocellular carcinoma | Q71347409 | ||
| Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer | Q72212122 | ||
| Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions | Q73383703 | ||
| Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus | Q73574276 | ||
| Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? | Q74452571 | ||
| Apoptosis, PCNA and p53 in hepatocellular carcinoma | Q74525528 | ||
| Role of FHIT in human cancer | Q77766615 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 228-231 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis | |
| P478 | volume | 11 |
| Q46583587 | Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas |
| Q38369053 | Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis |
| Q37277440 | Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea |
| Q37352174 | Gene expression and MR diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model |
| Q39523456 | HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells |
| Q28386062 | Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma |
| Q28389231 | Tumor suppressor and hepatocellular carcinoma |
Search more.